,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2018-09-06 06:01:00,"Chicago, IL - September 6, 2018 - Zacks.com announces the list of stocks featured in the Analyst Blog.",0.018321223556995392,0.008657502941787243,0.9730212688446045,neutral,0.009663720615208149
1,2018-09-06 06:01:00,Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.,0.021041298285126686,0.011407552286982536,0.9675511121749878,neutral,0.00963374599814415
2,2018-09-06 06:01:00,"Stocks recently featured in the blog include Pfizer PFE , Salesforce CRM , ADP ADP , General Motors GM and Southwest Airlines LUV .",0.019209597259759903,0.010212778113782406,0.970577597618103,neutral,0.008996819145977497
3,2018-09-06 06:01:00,"Today, Zacks is promoting its ''Buy'' stock recommendations.",0.3684377670288086,0.010614300146698952,0.6209479570388794,neutral,0.3578234612941742
4,2018-09-06 06:01:00,Get #1Stock of the Day pick for free.,0.0864095613360405,0.03249066323041916,0.8810997605323792,neutral,0.05391889810562134
5,2018-09-06 06:01:00,"Here are highlights from Wednesday's Analyst Blog:

The Zacks Research Daily presents the best research output of our analyst team.",0.2265114039182663,0.00957189779728651,0.7639166712760925,neutral,0.2169395089149475
6,2018-09-06 06:01:00,"Today's Research Daily features new research reports on 16 major stocks, including Pfizer, Salesforce and ADP.",0.037594594061374664,0.008746013045310974,0.9536593556404114,neutral,0.02884858101606369
7,2018-09-06 06:01:00,These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.,0.054846275597810745,0.007339245639741421,0.937814474105835,neutral,0.04750702902674675
8,2018-09-06 06:01:00,"You can see all of today's research reports here >>>

Pfizer 's shares have outperformed the peer group year-to-date (the stock is up +14.2% over this period vs. a +3.8% increase for the Zacks Large-Cap Pharmaceuticals industry).",0.9416761994361877,0.0393059067428112,0.01901780441403389,positive,0.902370274066925
9,2018-09-06 06:01:00,Pfizer has been working on strengthening its product portfolio through acquisitions and licensing deals.,0.9309698343276978,0.013153673149645329,0.055876411497592926,positive,0.917816162109375
10,2018-09-06 06:01:00,"However, Pfizer is facing top-line headwinds in the form of genericization of key drugs, supply challenges in the legacy Hospira portfolio, pricing pressure and rising competition.",0.022649234160780907,0.9541795253753662,0.023171275854110718,negative,-0.9315302968025208
11,2018-09-06 06:01:00,"Nonetheless, the Zacks analyst thinks new products like Ibrance, contribution from acquisitions, cost-cutting efforts, a lower tax rate and share buybacks should help the company achieve its guidance.",0.9407086968421936,0.01496468111872673,0.044326625764369965,positive,0.9257439970970154
12,2018-09-06 06:01:00,"Pfizer also boasts a strong pipeline and expects approximately 25 to 30 drug approvals through 2022, including around 15 products that have blockbuster potential.",0.8033297657966614,0.010806962847709656,0.1858632117509842,positive,0.7925227880477905
13,2018-09-06 06:01:00,Pfizer's growing immuno-oncology portfolio has strong potential.,0.8747050762176514,0.011693683452904224,0.1136011928319931,positive,0.8630114197731018
14,2018-09-06 06:01:00,Bavencio is being considered a key long-term growth driver for Pfizer.,0.7201189994812012,0.010345724411308765,0.26953521370887756,positive,0.7097733020782471
15,2018-09-06 06:01:00,"In oncology, Pfizer has four potential medicines under FDA's priority review.",0.042485423386096954,0.008258581161499023,0.9492560625076294,neutral,0.03422684222459793
16,2018-09-06 06:01:00,(You can read the full research report on Pfizer here >>> ).,0.013400020077824593,0.013333904556930065,0.9732661247253418,neutral,6.611552089452744e-05
17,2018-09-06 06:01:00,"Shares of Strong-Buy ranked Salesforce have handily beaten the broader Tech sector over the past year, with the stock up nearly three times the Zacks Technology sector's +20.2% gain.",0.9040123224258423,0.070137158036232,0.025850502774119377,positive,0.8338751792907715
18,2018-09-06 06:01:00,Salesforce reported stellar Q2 results and provided a strong outlook.,0.9448690414428711,0.01861121691763401,0.036519717425107956,positive,0.926257848739624
19,2018-09-06 06:01:00,The Zacks analyst thinks the company's diverse cloud offerings and strong spending on digital marketing remain the catalysts.,0.8645957708358765,0.01213808637112379,0.12326616793870926,positive,0.8524577021598816
20,2018-09-06 06:01:00,Management is extremely optimistic about enhancement of customer experience that has aided growth of the cloud segment.,0.9219916462898254,0.012629857286810875,0.06537846475839615,positive,0.9093617796897888
21,2018-09-06 06:01:00,"Additionally, strategic acquisitions and the resultant synergies are anticipated to prove conducive to growth over the long run.",0.9254710078239441,0.013231851160526276,0.0612972192466259,positive,0.912239134311676
22,2018-09-06 06:01:00,"Furthermore, the company's move of utilizing other data center operators like Amazon and Alphabet's geographical reach to expand its international business is commendable and will help it in achieving its targeted $23 billion sales mark by 2022.",0.9440549612045288,0.01475099939852953,0.04119410738348961,positive,0.9293039441108704
23,2018-09-06 06:01:00,"Nonetheless, stiff competition, currency fluctuations and an increase in investments for international expansions and data centers could negatively impact near-term profitability.",0.023556221276521683,0.9386168122291565,0.03782694414258003,negative,-0.9150605797767639
24,2018-09-06 06:01:00,(You can read the full research report on Salesforce here >>> ).,0.012213421985507011,0.013723894022405148,0.9740626215934753,neutral,-0.0015104720368981361
25,2018-09-06 06:01:00,"ADP 's shares have gained +34.9% over the past year, outperforming the Zacks Outsourcing industry, which has gained +30.6% over the same period.",0.955674946308136,0.026815399527549744,0.01750960759818554,positive,0.928859531879425
26,2018-09-06 06:01:00,"ADP reported strong fourth-quarter fiscal 2018 results, wherein both earnings and revenues surpassed expectations.",0.9528928995132446,0.02273254096508026,0.02437445893883705,positive,0.9301603436470032
27,2018-09-06 06:01:00,"The Zacks analyst thinks ADP holds a dominant position in the payroll processing and HCM market, primarily due to its robust product portfolio.",0.8839592337608337,0.01271720603108406,0.10332352668046951,positive,0.8712420463562012
28,2018-09-06 06:01:00,Acquisitions have also been a key growth catalyst for the company.,0.859085738658905,0.012120168656110764,0.12879417836666107,positive,0.8469655513763428
29,2018-09-06 06:01:00,"Further, the company's strong balance sheet enables it to continue with its shareholder friendly activities alongside strategic buyouts and investments on product development.",0.8945125341415405,0.012179112993180752,0.09330835193395615,positive,0.8823333978652954
30,2018-09-06 06:01:00,"However, ADP faces significant competition in each of its product lines.",0.1418006867170334,0.0821334719657898,0.7760658860206604,neutral,0.05966721475124359
31,2018-09-06 06:01:00,"Failure to meet varying client demands with updated technologies might reduce the demand for its solutions and services, thus hampering its position in the market.",0.018372589722275734,0.9639249444007874,0.01770254783332348,negative,-0.9455523490905762
32,2018-09-06 06:01:00,"Further, the company's dependence on its payroll, financial, accounting, and other data processing systems remains a concern.",0.021766001358628273,0.7368914484977722,0.24134257435798645,negative,-0.7151254415512085
33,2018-09-06 06:01:00,(You can read the full research report on ADP here >>> ).,0.013567078858613968,0.013299237936735153,0.9731336832046509,neutral,0.0002678409218788147
34,2018-09-06 06:01:00,Other noteworthy reports we are featuring today include General Motors and Southwest Airlines.,0.023540280759334564,0.006920491810888052,0.9695392847061157,neutral,0.016619788482785225
35,2018-09-06 06:01:00,Looking for Stocks with Skyrocketing Upside?,0.09469357132911682,0.09826507419347763,0.807041347026825,neutral,-0.0035715028643608093
36,2018-09-06 06:01:00,Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.,0.41462862491607666,0.01087752915918827,0.5744938254356384,neutral,0.40375110507011414
37,2018-09-06 06:01:00,"Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021.",0.8838319182395935,0.03136736899614334,0.08480073511600494,positive,0.8524645566940308
38,2018-09-06 06:01:00,"Early investors stand to make a killing, but you have to be ready to act and know just where to look.",0.19955629110336304,0.018484661355614662,0.781959056854248,neutral,0.18107162415981293
39,2018-09-06 06:01:00,"See the pot trades we're targeting>>

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.",0.0735645741224289,0.005033371038734913,0.9214020371437073,neutral,0.06853120028972626
40,2018-09-06 06:01:00,"Continuous coverage is provided for a universe of 1,150 publicly traded stocks.",0.036364275962114334,0.004866600502282381,0.9587691426277161,neutral,0.03149767592549324
41,2018-09-06 06:01:00,Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance.,0.054108913987874985,0.005191051866859198,0.9407000541687012,neutral,0.04891786351799965
42,2018-09-06 06:01:00,Recommendations and target prices are six-month time horizons.,0.013092893175780773,0.007127966266125441,0.9797791242599487,neutral,0.0059649269096553326
43,2018-09-06 06:01:00,"Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar.",0.044983625411987305,0.5624399185180664,0.3925764560699463,negative,-0.5174562931060791
44,2018-09-06 06:01:00,They're virtually unknown to the general public.,0.035764459520578384,0.0785161554813385,0.885719358921051,neutral,-0.04275169596076012
45,2018-09-06 06:01:00,"Yet today's 220 Zacks Rank #1 ""Strong Buys"" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015.",0.6580293774604797,0.017276067286729813,0.32469451427459717,positive,0.6407533288002014
46,2018-09-06 06:01:00,Its average gain has been a stellar +26% per year.,0.8422174453735352,0.0191669799387455,0.13861553370952606,positive,0.8230504393577576
47,2018-09-06 06:01:00,See these high-potential stocks free >>.,0.12527841329574585,0.05778927728533745,0.8169323205947876,neutral,0.0674891322851181
48,2018-09-06 06:01:00,"Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.",0.01284766010940075,0.009404126554727554,0.9777481555938721,neutral,0.003443533554673195
49,2018-09-06 06:01:00,Past performance is no guarantee of future results.,0.023727279156446457,0.008731111884117126,0.9675416350364685,neutral,0.01499616727232933
50,2018-09-06 06:01:00,Inherent in any investment is the potential for loss.,0.023265572264790535,0.09617827832698822,0.8805561661720276,neutral,-0.07291270792484283
51,2018-09-06 06:01:00,"This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security.",0.011962415650486946,0.010706594213843346,0.9773310422897339,neutral,0.0012558214366436005
52,2018-09-06 06:01:00,No recommendation or advice is being given as to whether any investment is suitable for a particular investor.,0.01822577603161335,0.008984367363154888,0.9727898240089417,neutral,0.009241408668458462
53,2018-09-06 06:01:00,"It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable.",0.020858757197856903,0.007662615738809109,0.9714785814285278,neutral,0.013196141459047794
54,2018-09-06 06:01:00,All information is current as of the date of herein and is subject to change without notice.,0.01124907098710537,0.013303965330123901,0.9754469990730286,neutral,-0.002054894343018532
55,2018-09-06 06:01:00,Any views or opinions expressed may not reflect those of the firm as a whole.,0.008276145905256271,0.021656149998307228,0.9700676798820496,neutral,-0.013380004093050957
56,2018-09-06 06:01:00,"Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities.",0.009504852816462517,0.012596068903803825,0.9778990745544434,neutral,-0.0030912160873413086
57,2018-09-06 06:01:00,These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs.,0.14585068821907043,0.02033580094575882,0.8338135480880737,neutral,0.1255148947238922
58,2018-09-06 06:01:00,These are not the returns of actual portfolios of stocks.,0.010538044385612011,0.012450686655938625,0.9770112633705139,neutral,-0.0019126422703266144
59,2018-09-06 06:01:00,The S&P 500 is an unmanaged index.,0.022511588409543037,0.0801919475197792,0.8972964882850647,neutral,-0.05768036097288132
60,2018-09-06 06:01:00,Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.,0.01078665629029274,0.015373211354017258,0.9738401174545288,neutral,-0.004586555063724518
61,2018-09-06 06:01:00,Want the latest recommendations from Zacks Investment Research?,0.03539300337433815,0.011573811061680317,0.9530332088470459,neutral,0.023819193243980408
62,2018-09-06 06:01:00,"Today, you can download 7 Best Stocks for the Next 30 Days.",0.05069372057914734,0.007019792217761278,0.9422864317893982,neutral,0.04367392882704735
63,2018-09-06 06:01:00,"Click to get this free report

To read this article on Zacks.com click here.",0.020684564486145973,0.03315984085202217,0.9461556077003479,neutral,-0.012475276365876198
64,2018-09-06 06:01:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204561054706573,0.01563790813088417,0.9741575717926025,neutral,-0.005433347076177597
